Azoles for treatment of fungal infections
US6300353A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1999 |
| Grant date | Oct 9, 2001 |
| Priority date | — |
| Expiry date | Mar 5, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Azole derivatives of the formula I ##STR1## wherein PA1 R.sup.14, R.sup.15 are each independently hydrogen or fluorine, PA1 T is a group of the formula: ##STR2## wherein PA2 R.sup.9 is pyrrolidinyl or a group A--NH--B--, PA2 A is hydrogen or straight-chain or branched C.sub.1 -C.sub.5 alkyl; PA2 B is straight-chain or branched C.sub.1 -C.sub.4 alkylene, --CH.sub.2 --CONH--CH.sub.2 or --CH.sub.2 CH.sub.2 CH.sub.2 --CH(NH.sub.2); and PA2 X.sup.- is a pharmaceutically acceptable anion; and pharmaceutically acceptable salts of said compounds, and hydrates and solvates of the compounds of formula I and the salts thereof can be used in the production of medicaments for treating fungal infections and mycoses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.